|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based payments | |||||
| Interest and income taxes paid, net | |||||
| Finance income | |||||
| (Gain) loss on disposal of property, plant and equipment | |||||
| Gain on the sale of a business | |||||
| Finance expense | |||||
| Amortization of deferred income from government grants | |||||
| Gain on acquisition of joint venture interest | |||||
| Deferred income taxes | |||||
| Impairment charges | |||||
| Other operating activities | |||||
| Change in assets and liabilities: | |||||
| Receivables, prepayments and other assets | |||||
| Inventories | |||||
| Trade and other payables | |||||
| Interest received | |||||
| Net change in working capital | |||||
| Interest received | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Purchases of property, plant and equipment and intangible assets | |||||
| Acquisitions, net of cash acquired | |||||
| Proceeds from government grants | |||||
| Proceeds from sale of property, plant and equipment and intangible assets | |||||
| Purchases of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Purchases of equity securities | |||||
| Proceeds from sale of a business | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Repayments of shareholder loan | |||||
| Repayments of debt and lease obligations | |||||
| Proceeds from government grants | |||||
| Increase in restricted cash | |||||
| Net proceeds from borrowings | |||||
| Proceeds from issuance of equity instruments | |||||
| Purchase of treasury stock | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at the end of the year | |||||
Loading...